Thursday, December 14, 2017 10:15 PM ET
Significant Insider Selling in Shares of Sage Therapeutics
A filing with the SEC today revealed a significant insider sale of Sage Therapeutics shares as — Albert Robichaud, Officer — sold 60,000 shares in the company having a market value of approximately $9,565,957. This is the first insider buy/sell trade in the past 90 days.
This number of buy-sell trades at Sage Therapeutics is near average for the 188 member peer company. The Biotechnology & Medical Research peer group saw 168 buy/sell trades during this period for an average of 0.9 transactions per company. However, trading at Sage Therapeutics represents a lower number of shares per transaction. Within the peer group there were 27,158,124 shares purchased and 23,949,949 shares sold with company insiders acquiring 26,735 shares on average over this time period.
The data obtained in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.